DeutschNewstral
Article
bizjournals.com on 2020-03-20 11:13
Maryland biotech CEO: Virus outbreak won't stop opening of Boston R&D hub
Related news
- Cambridge biotech plans manufacturing hub in Marylandbizjournals.com
- MedImmune, Tech Council of Maryland chart state's path to becoming a biotech hubbizjournals.com
- Maryland biotech looks for lifeline following restructuringbizjournals.com
- Maryland biotech expanding into new Gaithersburg headquartersbizjournals.com
- Maryland biotech expanding into new headquartersbizjournals.com
- Maryland biotech NexImmune files for IPObizjournals.com
- Another Duchenne-focused biotech joins the Boston area biotech hubbizjournals.com
Maryland-Michigan canceled by Wolverines’ virus outbreakseattletimes.com- AMaryland health officials investigate stomach flu outbreakapnewsarchive.com
- Ohio biotech moves to Maryland, picks up $175K in incentivesbizjournals.com
- Janssen Biotech signs deal to buy Maryland immunotherapy companybizjournals.com
- Maryland company to spin out new publicly traded cancer biotechbizjournals.com
- Biotech with large Triangle presence buying Maryland firm for $1.2Bbizjournals.com
- British investor adds another $40 million to Maryland biotech companybizjournals.com
- Maryland biotech lands federal approval for superbug testing systembizjournals.com
- Dublin biotech signs lease for big expansion in Marylandbizjournals.com
- Maryland biotech earns FDA approval for pediatric ADHD drugbizjournals.com
- Bringing biotech to market faster in Montgomery County, Marylandbizjournals.com
- Maryland biotech receives FDA approval for autoimmune treatmentbizjournals.com